Basic Guidelines for Bacteriophage Isolation and Characterization.

Q3 Biochemistry, Genetics and Molecular Biology Recent patents on biotechnology Pub Date : 2023-01-01 DOI:10.2174/1872208317666221017094715
Safia Samir
{"title":"Basic Guidelines for Bacteriophage Isolation and Characterization.","authors":"Safia Samir","doi":"10.2174/1872208317666221017094715","DOIUrl":null,"url":null,"abstract":"<p><p>The world is on the cusp of a post-antibiotic period. A century ago, before the advent of antibiotics, bacteriophage therapy was the treatment of choice for bacterial infections. Although bacteriophages have yet to be approved as a treatment in Western medicine, researchers and clinicians have begun to anticipate phage therapy. Bacteriophages are viruses that depend on bacterial cell metabolism to multiply. They offer a promising alternative to the use of antibiotics and an excellent antibacterial option for combating multidrug resistance in bacteria. However, not every phage is suitable for phage therapy. In particular, prophages should not be used because they can lysogenize host cells instead of lysing them. To offer adequate therapeutic options for patients suffering from various infectious diseases, a wide selection of different phages is needed. While there is no evidence of direct toxicity induced by phage particles, it is crucial to study mammalian cell-phage interactions. This requires phage preparations to be free of bacterial cells, toxins and other compounds to avoid skewing host responses. Negative staining of purified viruses and electron microscopy remain the gold standard in the identification of bacteriophages. Interestingly, genomics has greatly changed our understanding of phage biology. Bacteriophage genome sequencing is essential to obtain a complete understanding of the bacteriophages' biology and to obtain confirmation of their lifestyle. Full genetic sequencing of bacteriophage will enable a better understanding of the phage-encoded proteins and biomolecules (especially phage lytic enzymes) involved in the process of bacterial cell lysis and death. Mass spectrometry can be used for the identification of phage structural proteins. The use of lytic phages as biocontrol agents requires the most appropriate and standard methods to ensure application safety. This review pursues recent research and methods in molecular biology for the isolation and characterization of phages to facilitate follow-up and implementation of work for other researchers. Patents related to this topic have been mentioned in the text.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent patents on biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1872208317666221017094715","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 1

Abstract

The world is on the cusp of a post-antibiotic period. A century ago, before the advent of antibiotics, bacteriophage therapy was the treatment of choice for bacterial infections. Although bacteriophages have yet to be approved as a treatment in Western medicine, researchers and clinicians have begun to anticipate phage therapy. Bacteriophages are viruses that depend on bacterial cell metabolism to multiply. They offer a promising alternative to the use of antibiotics and an excellent antibacterial option for combating multidrug resistance in bacteria. However, not every phage is suitable for phage therapy. In particular, prophages should not be used because they can lysogenize host cells instead of lysing them. To offer adequate therapeutic options for patients suffering from various infectious diseases, a wide selection of different phages is needed. While there is no evidence of direct toxicity induced by phage particles, it is crucial to study mammalian cell-phage interactions. This requires phage preparations to be free of bacterial cells, toxins and other compounds to avoid skewing host responses. Negative staining of purified viruses and electron microscopy remain the gold standard in the identification of bacteriophages. Interestingly, genomics has greatly changed our understanding of phage biology. Bacteriophage genome sequencing is essential to obtain a complete understanding of the bacteriophages' biology and to obtain confirmation of their lifestyle. Full genetic sequencing of bacteriophage will enable a better understanding of the phage-encoded proteins and biomolecules (especially phage lytic enzymes) involved in the process of bacterial cell lysis and death. Mass spectrometry can be used for the identification of phage structural proteins. The use of lytic phages as biocontrol agents requires the most appropriate and standard methods to ensure application safety. This review pursues recent research and methods in molecular biology for the isolation and characterization of phages to facilitate follow-up and implementation of work for other researchers. Patents related to this topic have been mentioned in the text.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
噬菌体分离和鉴定的基本指南。
世界正处于后抗生素时代的风口浪尖。一个世纪前,在抗生素出现之前,噬菌体疗法是治疗细菌感染的首选疗法。尽管噬菌体尚未被批准作为一种西医治疗方法,但研究人员和临床医生已经开始期待噬菌体治疗。噬菌体是依靠细菌细胞代谢繁殖的病毒。它们为抗生素的使用提供了一个有希望的替代方案,也是对抗细菌多药耐药性的一个极好的抗菌选择。然而,并不是每个噬菌体都适合噬菌体治疗。特别是,不应该使用噬菌体,因为它们可以溶解宿主细胞而不是溶解它们。为了给患有各种传染病的患者提供适当的治疗选择,需要广泛选择不同的噬菌体。虽然没有证据表明噬菌体颗粒直接诱导毒性,但研究哺乳动物细胞-噬菌体相互作用至关重要。这就要求噬菌体制剂不含细菌细胞、毒素和其他化合物,以避免扭曲宿主的反应。纯化病毒的阴性染色和电子显微镜仍然是鉴定噬菌体的金标准。有趣的是,基因组学极大地改变了我们对噬菌体生物学的理解。噬菌体基因组测序对于全面了解噬菌体的生物学和确定它们的生活方式至关重要。噬菌体的全基因测序将使我们更好地了解噬菌体编码的蛋白质和生物分子(特别是噬菌体裂解酶)参与细菌细胞裂解和死亡的过程。质谱法可用于噬菌体结构蛋白的鉴定。使用噬菌体作为生物防治剂需要最合适和标准的方法来确保应用安全。本文综述了噬菌体分子生物学中分离和表征噬菌体的最新研究和方法,以促进其他研究人员的后续工作和实施。与此主题相关的专利已在文中提到。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Recent patents on biotechnology
Recent patents on biotechnology Biochemistry, Genetics and Molecular Biology-Biotechnology
CiteScore
2.90
自引率
0.00%
发文量
51
期刊介绍: Recent Patents on Biotechnology publishes review articles by experts on recent patents on biotechnology. A selection of important and recent patents on biotechnology is also included in the journal. The journal is essential reading for all researchers involved in all fields of biotechnology.
期刊最新文献
Phytochemical Analysis and Antimicrobial Potential of Parthenium hysterophorous and Lantana camara. The Landscape of Products for Diabetic Peripheral Neuropathy: A Scientific and Patent Systematic Review. The Role of Mycorrhizal Fungi in Orchids Mycobiont and Orchids. Exploration of Developmental Variants of Predatory Ladybird, Coccinella septumpunctata L. (Coleoptera: Coccinellidae) on an Artificial Diet. Emerging Methods in the Identification of Bacterial Respiratory Tract Pathogens.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1